Jeffrey W. Sherman, EVP and Chief Medical Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 191,484 shares at $70.31 ($13.6M) on 2020-12-07, disclosed to the SEC on 2020-12-09.
Open-market sale of $13.6M HZNP by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.31 | 36,389 | $2.6M | 18.8% |
| 2 | $70.31 | 36,389 | $2.6M | 18.8% |
| 3 | $71.52 | 16,200 | $1.2M | 8.5% |
| 4 | $72.24 | 10,489 | $758K | 5.6% |
| 5 | $72.24 | 10,489 | $758K | 5.6% |
| 6 | $70.60 | 9,631 |
| $680K |
| 5.0% |
| 7 | $70.60 | 9,631 | $680K | 5.0% |
| 8 | $71.32 | 31,133 | $2.2M | 16.3% |
| 9 | $71.32 | 31,133 | $2.2M | 16.3% |
| Total | $70.98 avg | 191,484 | $13.6M | 100% |
| Filing → |
| XERS | BUY | 2023-11-29 | $10K | — | Filing → |
| HZNP | SELL | 2023-01-12 | $1.5M | — | Filing → |
| HZNP | SELL | 2023-01-06 | $1.2M | — | Filing → |